Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-26 @ 1:35 AM
Study NCT ID:
NCT00745433
Status:
COMPLETED
Last Update Posted:
2023-11-02
First Post:
2008-09-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-01
First Submit QC Date:
None
Study First Post Date:
2008-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-02
Last Update Post Date Type:
ACTUAL